Tempus shared on X:
“October is Breast Cancer Awareness Month, a time to honor the strength of each individual facing a diagnosis and to reflect on the power of equipping physicians with meaningful insights when decisions matter most.
When Romy was diagnosed with triple-negative breast cancer, Tempus genomic testing helped arm her physician with insights that led to a targeted combination of immunotherapy and chemotherapy. She now has no evidence of disease.
Learn more about Romy’s story.”
This also can be interesting:
